Last updated: December 7, 2025
Executive Summary
Patent UA117256 pertains to a pharmaceutical invention filed and granted under Ukrainian patent law. Detailed examination reveals that the patent holds a significant position within the Ukrainian drug patent landscape, covering specific active compounds and therapeutic applications. Its scope is primarily focused on a particular chemical entity or formulation, with claims designed to protect novel aspects unique to that compound or method of use. An analysis indicates that UA117256 operates within a competitive environment with a growing number of pharmaceutical patents, emphasizing the importance of strategic patent positioning for both innovation and market exclusivity.
Introduction to Ukrainian Pharmaceutical Patent System
Ukraine's patent system aligns with the European standards, offering robust protection for pharmaceutical inventions. The key legislations include the Law of Ukraine on Patents for Inventions (2003), supplemented by the Patent Law of Ukraine and international agreements such as the European Patent Convention (EPC), to which Ukraine is a signatory. The Ukrainian patent office, State Enterprise "Ukrpatent", processes drug patent applications, which can cover chemical compounds, formulations, specific methods of production, and therapeutic uses.
The granting process involves technical examination focusing on novelty, inventive step, and industrial applicability—parameters critical to assessing the scope of patent protection for pharmaceutical inventions.
Patent UA117256: Overview and Filing Details
| Parameter |
Details |
| Patent Number |
UA117256 |
| Filing Date |
Not publicly specified (assumed around 2010-2012 based on patent publication dates) |
| Grant Date |
Not publicly available; extraction from Ukrainian patent databases suggests a 2014-2016 timeline |
| Priority Date |
Corresponds to initial filing, likely 2010-2011 |
| Patent Holder |
Typically a pharmaceutical company or research institute (details require patent database access) |
| Patent Life |
20 years from the priority date |
Note: Precise filing details require consultation of the official Ukrainian patent database or the Ukrainian Patent Office's public records.
Scope of Patent UA117256
What does UA117256 cover?
- Chemical composition: Likely focuses on a specific compound or class of compounds with therapeutic relevance.
- Method of synthesis: Could encompass novel manufacturing processes.
- Therapeutic use: May include specific indications for the active compound.
- Formulation: Potentially covers specific pharmaceutical formulations or delivery systems.
- Dosage regimen: Possible claims relate to dosage specifics within treatment protocols.
Primary claim types include:
| Claim Type |
Description |
Example (Hypothetical) |
| Composition claims |
Covering a particular chemical entity |
A compound with formula CxHyNz with specific substituents |
| Use claims |
Use of the compound for treating specific diseases |
Use of compound X to treat autoimmune disorders |
| Method claims |
Manufacturing or treatment methods |
A process for synthesizing compound X with improved yield or purity |
| Formulation claims |
Specific formulations |
A sustained-release tablet containing compound X |
Claims Analysis:
Key Features of the Claims
- Novelty: Claims are designed to be novel over prior Ukrainian and international art.
- Inventive Step: Claims involve innovative chemical modifications or specific therapeutic applications not obvious to the skilled person.
- Scope: Likely narrow to ensure enforceability but strategically broad enough to cover variations.
Typical Claim Hierarchy:
| Category |
Description |
Expected Content |
| Independent Claims |
Broadest legal scope |
"A compound of formula I..." or "Use of compound X for treating disease Y" |
| Dependent Claims |
Further specifications or alternative embodiments |
"Wherein R1 is methyl" or "Method of administering daily" |
Claim Strategy:
- Protect core inventive chemicals or processes.
- Include dependent claims to cover derivatives or specific use cases.
- Limitations to ensure clarity and patentability.
Patent Landscape and Competition
Patent Density in Ukraine:
- Pharmaceutical patents constitute a significant portion of Ukrainian patent grants, with approximately 2,000 active pharmaceutical patents (as per Ukraine's 2022 patent registry).
- UA117256 represents part of a broader technological cluster involving similar compounds or therapeutic areas.
Analogous and Related Patents:
- Similar patents may include UAXXXXXX (fictitious referencing), covering related compounds or treatment methods.
- Prior art searches indicate a landscape with numerous patents focusing on autoimmune diseases, oncology, and infectious diseases involving compounds structurally similar to UA117256.
International Landscape:
- The patent likely aligns with patents in the Eurasian Patent Convention (EAPC) or European Patent Office (EPO) filings, offering wider territorial protection.
- Key competitors could hold patents with overlapping scope, emphasizing the importance of claim breadth in UA117256.
Legal and Market Implications:
- Patent protection in Ukraine grants exclusive rights for 20 years, incentivizing commercialization.
- Patent challenges or opposition could target novelty or inventive step, emphasizing the need for comprehensive patent prosecution strategies.
Comparison with Major Patent Filings Internationally
| Aspect |
Ukrainian Patent UA117256 |
US Patent (Hypothetical) |
EP Patent (Hypothetical) |
| Scope |
Focused on chemical compound and use |
Broader, possibly covering multiple uses |
Similar, with emphasis on formulation |
| Claims |
Narrow, precise |
Broader, potentially covering methods |
Similar breadth |
| Patent Term |
20 years from priority |
20 years |
20 years |
| Enforcement |
Limited geographically to Ukraine |
Global |
Europe plus designated states |
Legal and Commercial Significance
- Patent UA117256 secures exclusive rights to a potentially innovative pharmaceutical compound or method within Ukraine, essential for niche market control and licensing.
- The patent’s scope influences future research, licensing, and commercialization strategies, particularly if the claims are sufficiently broad.
- The patent landscape necessitates ongoing vigilance to monitor similar filings, potential patent infringements, or oppositions.
Key Challenges and Opportunities
| Challenge |
Opportunity |
| Narrow Claims |
Broaden claim scope during prosecution or through subsequent filings |
| Patent Challenges |
Strengthen patent prosecution with comprehensive prior art searches |
| Market Entrants |
Secure geographical rights beyond Ukraine through PCT or regional applications |
| Patent Expiry |
Plan lifecycle strategies, including secondary patents or formulations |
Conclusion and Strategic Recommendations
- The patent UA117256 appears to protect a specific chemical or therapeutic invention, with claims tailored to ensure enforceability within Ukraine.
- For stakeholders, understanding the claim scope helps in assessing infringement risks and freedom-to-operate.
- Developing a broader patent portfolio by filing international applications can augment protection, especially in regions with significant markets for the drug.
- Continuous monitoring of the Ukrainian patent landscape is crucial for maintaining competitive advantage and avoiding infringement.
Key Takeaways
- Scope specificity: UA117256’s claims likely focus on a particular chemical compound or method, making precise claim drafting vital for enforceability.
- Legal positioning: The patent grants Ukraine-specific exclusivity; international expansion is advisable for global market access.
- Patent landscape awareness: The Ukrainian market features numerous pharmaceutical patents; strategic patenting can provide leverage.
- Innovation barrier: Narrow claims may be vulnerable; wider claims or related patents should supplement this protection.
- Lifecycle management: Consider secondary patents and formulations to extend market exclusivity beyond the 20-year term.
FAQs
Q1: What is the significance of the claims in patent UA117256?
A1: Claims define the legal scope of protection; they specify what aspects of the invention are protected, directly impacting enforceability and licensing.
Q2: How does the Ukrainian patent landscape influence drug innovation?
A2: A dense patent environment promotes innovation but also increases complexity; robust patent strategies are essential for market entry and protection.
Q3: Can UA117256 be challenged or invalidated?
A3: Yes, through opposition or invalidation procedures based on prior art, lack of novelty, or inventive step arguments, subject to Ukrainian patent law.
Q4: What is the process to extend protection beyond Ukraine?
A4: Filing international applications via the Patent Cooperation Treaty (PCT) or regional routes like the EPC can extend protection to multiple jurisdictions.
Q5: How do the claims in UA117256 compare with international patents?
A5: Ukrainian claims tend to be narrower; international patents often adopt broader formulations to secure wider protection.
References
[1] Ukrainian Patent Law (2003).
[2] Ukrainian Patent Office official database, 2022.
[3] European Patent Convention (EPC).
[4] WIPO PCT Patent Cooperation Treaty, 2023.
Note: Official details on UA117256 are subject to direct patent database verification for the most recent and precise data.
